folP1 Resolved · high auto-curated

H37Rv Rv3608c · MTBC0 - · 280 aa · 4049138–4049980 H37Rv (-) · RefSeq YP_177997.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)dihydropteroate synthase
MTBC0 PGAP re-annotation—
Revised (this work)Dihydropteroate synthase. Pfam: Pterin_bind (PF00809.29).
Functional category (TubercuList)intermediary metabolism and respiration

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

Annotated on the H37Rv protein: this gene has no 1:1 ancestral MTBC0 anchor (PE/PPE, paralogue, IS element, or otherwise unanchored CDS).

In the literature (TB corpus sweep) studied as much outside M. tuberculosis

The biology of this gene is documented at least as much outside M. tuberculosis as within it — 58 record(s) in a non-TB mycobacterial context (species named in the verified sample: M. leprae 38, M. smegmatis 1) versus 9 in a TB context, two separate queries. Mycobacterial genetics is largely done in M. smegmatis, so part of what is “known” about this gene is known by proxy.

Caveat: IMPORTANT — 'better studied elsewhere' does NOT mean 'function established in M. tuberculosis'. Findings obtained in M. smegmatis (a non-pathogenic, fast-growing species with a different lifestyle and regulation), or in M. marinum / M. leprae / M. abscessus, do NOT transfer automatically to M. tuberculosis. Treat this body of work as CONTEXT to verify, not as settled knowledge.

64 TB publications mention this gene. 64 publications discuss this gene. **Its biology is documented at least as much OUTSIDE M. tuberculosis as within it**: queried separately, 58 records carry a non-TB mycobacterial context (species named in the 40-record verified sample: M. leprae (38), M. smegmatis (1)) against 9 with a M. tuberculosis context. The context counts come from distinct PubMed queries (each with its own context filter), so they are not parts of the total above and need not add up to it. Mycobacterial genetics is largely done in M. smegmatis, so part of what is 'known' about this gene is known by proxy. reformulation, not a quotation

5 of 64: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Assessment of Antimicrobial Resistance in M. leprae Strains From Kiribati. doi:10.1111/tmi.70146 2026
Resistance to anti-leprosy drugs in multi-bacillary leprosy patients: The need for transformative action. doi:10.25259/IJDVL_1842_2024 2026
Unraveling Drug Resistance in Mycobacterium leprae: Exploring Genetic Mutations to Enhance Treatment Strategies for Human Leprosy-A Narrative Review. doi:10.1155/ijm/7204337 2025
Geographical trends of drug-resistant strains of Mycobacterium leprae in TLM hospitals: insights from a four-year study across eleven hospitals in eight Indian States. doi:10.1007/s10096-025-05351-x 2026
Genotypic investigation of Mycobacterium leprae in patients with relapsing leprosy in Mato Grosso, Brazil. doi:10.1007/s00430-025-00864-w 2025
64 records returned by the alias sweep

Searched as: Rv3608c, folP1, Mb3638c, ML0224, MMAR_5111, MSMEG_6103, MAB_0535 — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Assessment of Antimicrobial Resistance in M. leprae Strains From Kiribati. doi:10.1111/tmi.70146 Trop Med Int Health 2026
Resistance to anti-leprosy drugs in multi-bacillary leprosy patients: The need for transformative action. doi:10.25259/IJDVL_1842_2024 Indian J Dermatol Venereol Leprol 2026
Geographical trends of drug-resistant strains of Mycobacterium leprae in TLM hospitals: insights from a four-year study across eleven hospitals in eight Indian States. doi:10.1007/s10096-025-05351-x Eur J Clin Microbiol Infect Dis 2026
Unraveling Drug Resistance in Mycobacterium leprae: Exploring Genetic Mutations to Enhance Treatment Strategies for Human Leprosy-A Narrative Review. doi:10.1155/ijm/7204337 Int J Microbiol 2025
Genotypic investigation of Mycobacterium leprae in patients with relapsing leprosy in Mato Grosso, Brazil. doi:10.1007/s00430-025-00864-w Med Microbiol Immunol 2025
Therapeutic failure of multidrug therapy for leprosy: A retrospective case series in a hyperendemic Brazilian City. doi:10.1371/journal.pntd.0013616 PLoS Negl Trop Dis 2025
Molecular Detection of Gene Mutation Related to Drug Resistance in Mycobacterium leprae. doi:10.4103/ijmy.ijmy_35_25 Int J Mycobacteriol 2025
Classic and new candidate markers for drug resistance in a large cohort of leprosy patients from the Amazon state, Brazil. doi:10.1128/aac.01550-24 Antimicrob Agents Chemother 2025
Novel mutations found in Mycobacterium leprae DNA repair gene nth from central India. doi:10.1016/j.jiac.2023.12.011 J Infect Chemother 2024
Origin and spread of leprosy in Suriname. A historical and biomedical study. doi:10.3389/fitd.2023.1258006 Front Trop Dis 2023
Hi-plex deep amplicon sequencing for identification, high-resolution genotyping and multidrug resistance prediction of Mycobacterium leprae directly from patient biopsies by using Deeplex Myc-Lep. doi:10.1016/j.ebiom.2023.104649 EBioMedicine 2023
Mycobacterium leprae and host immune transcriptomic signatures for reactional states in leprosy. doi:10.3389/fmicb.2023.1113318 Front Microbiol 2023
Drug Resistance (Dapsone, Rifampicin, Ofloxacin) and Resistance-Related Gene Mutation Features in Leprosy Patients: A Systematic Review and Meta-Analysis. doi:10.3390/ijms232012443 Int J Mol Sci 2022
Molecular Surveillance of Antimicrobial Resistance of Mycobacterium leprae from Leprosy Patients in Zhejiang Province, China. doi:10.2147/IDR.S368682 Infect Drug Resist 2022
Investigating drug resistance of Mycobacterium leprae in the Comoros: an observational deep-sequencing study. doi:10.1016/S2666-5247(22)00117-3 Lancet Microbe 2022
Sensitivity of different DNA extraction methods and PCR to detect resistance in patients with leprosy stratified by the bacilloscopic index. doi:10.1016/j.bjid.2022.102381 Braz J Infect Dis 2022
Antimicrobial Resistance among Leprosy Patients in Brazil: Real-World Data Based on the National Surveillance Plan. doi:10.1128/aac.02170-21 Antimicrob Agents Chemother 2022
Simultaneous Determination of Mycobacterium leprae Drug Resistance and Single-Nucleotide Polymorphism Genotype by Use of Nested Multiplex PCR with Amplicon Sequencing. doi:10.1128/JCM.00814-21 J Clin Microbiol 2021
Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India. doi:10.4269/ajtmh.19-0390 Am J Trop Med Hyg 2020
Emergence and Transmission of Drug-/Multidrug-resistant Mycobacterium leprae in a Former Leprosy Colony in the Brazilian Amazon. doi:10.1093/cid/ciz570 Clin Infect Dis 2020
Nested PCR and the TaqMan SNP Genotyping Assay enhanced the sensitivity of drug resistance testing of Mycobacterium leprae using clinical specimens of leprosy patients. doi:10.1371/journal.pntd.0007946 PLoS Negl Trop Dis 2019
Molecular surveillance of antimicrobial resistance and transmission pattern of Mycobacterium leprae in Chinese leprosy patients. doi:10.1080/22221751.2019.1677177 Emerg Microbes Infect 2019
A new Mycobacterium leprae dihydropteroate synthase variant (V39I) from Papua, Indonesia. doi:10.1016/j.heliyon.2019.e01279 Heliyon 2019
Report of a Leprosy case in Singapore: an age-old disease not to be forgotten in developed countries with low-prevalence settings. doi:10.1099/acmi.0.000014 Access Microbiol 2019
Genomic Reduction at TTC Repeats in the Bacterial Genome of Treated Cases of Hansen's Disease: A Possible Survival Mechanism of Mycobacterium leprae. doi:10.4103/ijd.IJD_90_18 Indian J Dermatol 2018
Proteomic analysis reveals that sulfamethoxazole induces oxidative stress in M. tuberculosis. doi:10.1016/j.tube.2018.05.010 Tuberculosis (Edinb) 2018
Dapsone Resistance in Leprosy Patients Originally from American Samoa, United States, 2010-2012. doi:10.3201/eid2408.180033 Emerg Infect Dis 2018
Prospective study on antimicrobial resistance in leprosy cases diagnosed in France from 2001 to 2015. doi:10.1016/j.cmi.2018.06.004 Clin Microbiol Infect 2018
RepTB: a gene ontology based drug repurposing approach for tuberculosis. doi:10.1186/s13321-018-0276-9 J Cheminform 2018
Resistance to anti leprosy drugs in multi-bacillary leprosy: A cross sectional study from a tertiary care centre in eastern Uttar Pradesh, India. doi:10.4103/ijdvl.IJDVL_34_16 Indian J Dermatol Venereol Leprol 2018
Antimicrobial resistance in leprosy: results of the first prospective open survey conducted by a WHO surveillance network for the period 2009-15. doi:10.1016/j.cmi.2018.02.022 Clin Microbiol Infect 2018
Update of Antitubercular Prodrugs from a Molecular Perspective: Mechanisms of Action, Bioactivation Pathways, and Associated Resistance. doi:10.1002/cmdc.201700424 ChemMedChem 2017
qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients. doi:10.1371/journal.pntd.0005506 PLoS Negl Trop Dis 2017
Mutations in the drug resistance-determining region of Mycobacterium lepromatosis isolated from leprosy patients in Mexico. doi:10.1111/1346-8138.13483 J Dermatol 2016
Leprosy Drug Resistance Surveillance in Colombia: The Experience of a Sentinel Country. doi:10.1371/journal.pntd.0005041 PLoS Negl Trop Dis 2016
Discovery of a potential lead compound for treating leprosy with dapsone resistance mutation in M. leprae folP1. doi:10.1039/c6mb00225k names it Mol Biosyst 2016
Unique TTC Repeat Base Pair Loss Mutation In Cases of Pure Neural Leprosy: A Survival Strategy of Mycobacterium Leprae? doi:10.4103/0019-5154.160478 Indian J Dermatol 2015
Drug resistance in Mycobacterium leprae from patients with leprosy in China. doi:10.1111/ced.12665 Clin Exp Dermatol 2015
Role of folP1 and folP2 Genes in the Action of Sulfamethoxazole and Trimethoprim Against Mycobacteria. doi:10.4014/jmb.1503.03053 names it J Microbiol Biotechnol 2015
Computational Modelling of Dapsone Interaction With Dihydropteroate Synthase in Mycobacterium leprae; Insights Into Molecular Basis of Dapsone Resistance in Leprosy. doi:10.1002/jcb.25180 J Cell Biochem 2015
Identification of primary drug resistance to rifampin in Mycobacterium leprae strains from leprosy patients in Amazonas State, Brazil. doi:10.1128/JCM.01688-14 J Clin Microbiol 2014
In vitro susceptibility of Mycobacterium tuberculosis to trimethoprim and sulfonamides in France. doi:10.1128/AAC.01683-13 Antimicrob Agents Chemother 2013
Detection of antibiotic resistance in leprosy using GenoType LepraeDR, a novel ready-to-use molecular test. doi:10.1371/journal.pntd.0001739 PLoS Negl Trop Dis 2012
Drug and multidrug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients. doi:10.1128/JCM.06561-11 J Clin Microbiol 2012
Real-time PCR and high-resolution melt analysis for rapid detection of Mycobacterium leprae drug resistance mutations and strain types. doi:10.1128/JCM.05183-11 J Clin Microbiol 2012
Transmission of dapsone-resistant leprosy detected by molecular epidemiological approaches. doi:10.1128/AAC.05236-11 Antimicrob Agents Chemother 2011
Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy. names it Lepr Rev 2011
Genotyping of Mycobacterium leprae from Brazilian leprosy patients suggests the occurrence of reinfection or of bacterial population shift during disease relapse. doi:10.1099/jmm.0.029389-0 J Med Microbiol 2011
Analysis of drug-resistant strains of Mycobacterium leprae in an endemic area of Vietnam. doi:10.1093/cid/ciq217 Clin Infect Dis 2011
Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance. doi:10.1128/AAC.01212-10 names it Antimicrob Agents Chemother 2011
Possible mode of emergence for drug-resistant leprosy is revealed by an analysis of samples from Mexico. Jpn J Infect Dis 2010
[Novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries]. doi:10.5025/hansen.79.257 Nihon Hansenbyo Gakkai Zasshi 2010
Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis. doi:10.1128/AAC.01197-08 Antimicrob Agents Chemother 2009
A novel method for simple detection of mutations conferring drug resistance in Mycobacterium leprae, based on a DNA microarray, and its applicability in developing countries. doi:10.1099/jmm.0.2008/002600-0 J Med Microbiol 2008
Biochemical and structural characterization of the putative dihydropteroate synthase ortholog Rv1207 of Mycobacterium tuberculosis. doi:10.1111/j.1574-6968.2008.01302.x FEMS Microbiol Lett 2008
[Study of rifampin and dapsone resistance in three patients with recurring leprosy]. doi:10.1590/s1020-49892008000200001 Rev Panam Salud Publica 2008
The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Lepr Rev 2007
Dihydropteroate synthase mutations in the folP1 gene predict dapsone resistance in relapsed cases of leprosy. doi:10.1086/498506 names it Clin Infect Dis 2006
Multidrug resistant Mycobacterium leprae from patients with leprosy. doi:10.1128/AAC.45.12.3635-3639.2001 Antimicrob Agents Chemother 2001
The prevalence of folP1 mutations associated with clinical resistance to dapsone, in Mycobacterium leprae isolates from South Korea. doi:10.1080/000349801300188447 names it Ann Trop Med Parasitol 2001
Simultaneous detection of Mycobacterium leprae and its susceptibility to dapsone using DNA heteroduplex analysis. doi:10.1128/JCM.39.6.2083-2088.2001 J Clin Microbiol 2001
Dapsone resistance in Mycobacterium leprae. Lepr Rev 2000
Dihydropteroate synthase of Mycobacterium leprae and dapsone resistance. doi:10.1128/AAC.44.6.1530-1537.2000 Antimicrob Agents Chemother 2000
Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae. Indian J Lepr 1999

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

IMPORTANT — 'better studied elsewhere' does NOT mean 'function established in M. tuberculosis'. Findings obtained in M. smegmatis (a non-pathogenic, fast-growing species with a different lifestyle and regulation), or in M. marinum / M. leprae / M. abscessus, do NOT transfer automatically to M. tuberculosis. Treat this body of work as CONTEXT to verify, not as settled knowledge. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 1 % of gene

NeighbourfolB (Rv3607c, - strand)
Overlap8 bp, 1 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

CRISPRi vulnerability

Vulnerability index -6.38 (95% CI -7.10 to -5.67). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in dihydrofolate biosynthesis (at the second step). Catalyzes the formation of the immediate precursor of FOLIC acid. It is implicated in resistance to sulfonamide [catalytic activity: 2-amino-4-hydroxy-6-hydroxymethyl-7,8-dihydropteridine diphosphate + 4-aminobenzoate = pyrophosphate + dihydropteroate].
Mycobrowser EC 2.5.1.15 · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3638c · 99.6% identity
M. leprae ML0224 · 77.1% identity
M. marinum MMAR_5111 · 76.8% identity
M. smegmatis MSMEG_6103 · 73.5% identity
M. orygis RJtmp_003715 · 98.9% identity
M. abscessus MAB_0535 · 61.8% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WND1 SwissProt · reviewed · Evidence at protein level
UniProt nameDihydropteroate synthase
EC (curated) EC 2.5.1.15
Curated functionCatalyzes the condensation of para-aminobenzoate (pABA) with 6-hydroxymethyl-7,8-dihydropterin diphosphate (DHPt-PP) to form 7,8-dihydropteroate (H2Pte), the immediate precursor of folate derivatives..; FUNCTION: Is involved in the bioactivation of the antituberculous drug para-aminosalicylic acid (PAS). PAS is a close structural analog of pABA and acts as an alternative substrate for DHPS, leading to hydroxy-dihydropteroate (H2PtePAS). Metabolomic studies show that PAS, despite its in vitro activity as a competitive inhibitor of DHPS, does not inhibit growth of M.tuberculosis by inhibiting DH.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category H Coenzyme transport and metabolism
Preferred namefolP
eggNOG descriptionCatalyzes the condensation of para-aminobenzoate (pABA) with 6-hydroxymethyl-7,8-dihydropterin diphosphate (DHPt-PP) to form 7,8-dihydropteroate (H2Pte), the immediate precursor of folate derivatives
Orthologous groupCOG0294
EC number EC 2.5.1.15
KEGG orthology K00796
KEGG pathways map00790, map01100
KEGG modules M00126, M00841
Gene Ontology (54) GO:0003674, GO:0003824, GO:0004156, GO:0005575, GO:0005622, GO:0005623, GO:0005737, GO:0005829, GO:0006082, GO:0006575, GO:0006725, GO:0006732 +42 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.483 · quasi-invariant (7 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 3 synonymous, 4 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.0 (low power) · 2 consensus substitution(s)
low power (2 canettii-consensus substitution(s)); present in M. canettii but dN/dS not reliable
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 78.7% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 13/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 54.4%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) ESD — not strictly essential

The two screens differ on the SCOPE of what is required: Tn-seq says essential (domain-level only) (ESD), CRISPRi says essential.

These two screens are not in plain contradiction here, but they do not say the same thing either, and the difference matters for what may be written about this gene. Tn-seq (DeJesus 2017) places the requirement on a SUB-REGION of the ORF and explicitly declines to call the whole gene essential; CRISPRi (Bosch 2021) calls the gene essential under partial knockdown. Both point to an important gene; they disagree on the SCOPE of what is required. Locate the domain before concluding, and note that a stretch carrying no TA site is invisible to Himar1 Tn-seq — neither essential nor dispensable can be inferred there. Here the CRISPRi estimate is a confident one (its `certain` flag is set, vulnerability index -6.382), so the disagreement is a genuine methodological tension rather than a weak fit. Atlas-wide, 26 gene(s) fall in this exact stratum, out of 27 showing this direction of disagreement.

DeJesus 2017 callESD · essential domain
What the call meansessential domain: only a SUB-REGION of the ORF is essential; the gene as a whole is NOT essential. Locate the domain before concluding, and beware that a region devoid of TA sites is invisible to Himar1 TnSeq (neither essential nor dispensable can be inferred).
TA sites (Himar1) 9 in the ORF — 7 in the essential state, 2 growth-defect, 0 non-essential, 0 growth-advantage. Saturation 0.222, mean read count 4. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 9 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.
Caveat`essential: true` here is the broad union (ES+ESD+GD) kept for backward compatibility; this gene is NOT strictly essential. Read n_sites_* before writing anything about essentiality. Read with some caution: only 9 TA (Himar1) sites in the whole ORF (atlas median 13). The DeJesus 2017 call rests on fewer independent observations than for a longer gene. If this gene overlaps a neighbour (see Genomic-neighbour overlap section below), some of these 9 sites may fall inside the neighbour's ORF rather than its own, leaving even fewer truly informative sites than the raw count suggests. (P20.3)

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Chemical-genetic target & druggability (PROSPECT) hypomorph tool strain

This gene is part of the PROSPECT collection of TetON transcriptional-knockdown (hypomorph) strains of essential M. tuberculosis genes, built as a sensitised background for chemical-genetic mechanism-of-action deconvolution. Being in the panel means the gene is an essential / vulnerable target for which a validated knockdown tool strain exists.

Hypomorph strainRv3608c-folP1-TetOn10.2 (TetON promoter 10)
Baseline knockdown fitness2.108 median doublings (across 6 screen pool(s)) — fewer doublings = stronger growth defect on knockdown
Used in target deconvolutionno (Excluded - noisy growth (conditions with GR>20))

Panel membership reflects essentiality/vulnerability and the availability of a genetic tool, not a specific molecular function; it never changes the verdict here. Source: Bond AN et al., Nat Commun 2025;16:9673 (doi:10.1038/s41467-025-64662-x); PROSPECT chemical-genetic platform.

Proteomics (mass spectrometry) detected

MS detectiondetected in 12 of 16 independent MS datasets
Integrated abundance45.8 ppm · rank 1812/3519 (48.5th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length280 aa
Molecular weight28.8 kDa
Theoretical pI5.08
GRAVY0.253 (hydrophobic)
Aliphatic index102.1
Aromaticity0.036
Instability index21.1 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
Pterin_bindPF00809.29 7.7e-879–255 Pterin binding enzyme

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 1eye (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 1 solved

PDBMethodResolutionCoverage
1eye X-ray diffraction 1.7 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (1 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 90.8

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
1eye-assembly1_A-2 1.00 0.97 0.89 0.97 95% 96% / 100% 2.0e-42 sig 1eye-assembly1_A-2 1.7 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF 6-HYDROXYMETHYL-7,8-DIHYDROPTEROATE SYNTHASE (DHPS) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 6-HYDROXYMETHYLPTERIN MONOPHOSPHATE
6omz-assembly1_A 1.00 0.96 0.92 0.94 74% 96% / 98% 2.9e-41 sig 6omz-assembly1_A Crystal Structure of Dihydropteroate synthase from Mycobacterium smegmatis with bound 6-hydroxymethylpterin-monophosphate
6q62-assembly1_A 1.00 0.89 0.86 0.89 43% 97% / 95% 1.4e-26 sig 6q62-assembly1_A Xanthomonas albilineans Dihydropteroate synthase in complex with (indole-2-carboxylic acid) and (6-chloroguanine)
6q62-assembly2_C 1.00 0.90 0.86 0.90 43% 97% / 95% 5.1e-26 sig 6q62-assembly2_C Xanthomonas albilineans Dihydropteroate synthase in complex with (indole-2-carboxylic acid) and (6-chloroguanine)
6pz2-assembly1_A-2 1.00 0.91 0.86 0.91 38% 96% / 98% 2.8e-25 sig 6pz2-assembly1_A-2 Crystal Structure of FolP (dihydropteroate synthase) from Colstridium difficile in the presence of pteroic acid

Foldseek search of the AlphaFold DB model (mean pLDDT 90.8, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 6

Upstream (5' on genome)folB (- strand, -8 bp gap)
Downstream (3' on genome)folE (- strand, -4 bp gap)
Predicted operon Rv3605c · folK · folB · folP1 · folE · ftsH

Neighbours from the H37Rv annotation (- strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 6: Rv3605c · folK · folB · folP1 · folE · ftsH — agrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3712) exponential phase: operon of 6, Rv3605c · Rv3606c · Rv3607c · Rv3608c · Rv3609c · Rv3610c (coverage 93.99)
not expressed (stationary phase) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (2 TF) Rv0047c (activates) · Rv1049 (represses)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: folB (dihydroneopterin aldolase), high confidence (score 1000, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair is recorded in a curated database (pathway or complex membership) for M. tuberculosis genes themselves (score ≥ 200): a curated association, not a measurement in this organism.

Showing the 15 strongest of this gene's 58 partners at medium confidence (21 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 58 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv3607c folB curated dihydroneopterin aldolase 999 1000 ctx neighborhood:882 cooccurence:455 coexpression:947 database:900 textmining:819
Rv3606c folK curated 2-amino-4-hydroxy-6-hydroxymethyldihydropteridinepyrophosphokinase 999 1000 ctx neighborhood:882 cooccurence:758 coexpression:945 database:900 textmining:571
Rv3609c folE GTP cyclohydrolase I 999 998 ctx neighborhood:881 fusion:460 cooccurence:539 coexpression:943 textmining:772
Rv2447c folC curated folylpolyglutamate synthase FolC 999 994 ctx fusion:840 coexpression:431 database:900 textmining:924
Rv3610c ftsH zinc metalloprotease FtsH 941 936 ctx neighborhood:867 coexpression:539
Rv1207 folP2 curated paralog dihydropteroate synthase 939 925 database:900
Rv0812 curated 4-amino-4-deoxychorismate lyase 926 919 database:900
Rv3605c hypothetical protein 882 882 ctx neighborhood:882
Rv2366c transmembrane protein 793 793 coexpression:793
Rv2365c hypothetical protein 753 754 coexpression:746
Rv3602c panC pantothenate synthetase 774 748 ctx neighborhood:661
Rv1604 impA inositol-monophosphatase ImpA 744 745 coexpression:736
Rv3604c dark transmembrane protein 736 737 ctx neighborhood:734
Rv1634 multidrug-efflux transporter 746 736 coexpression:732
Rv3601c panD aspartate 1-decarboxylase 679 663 ctx neighborhood:661

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Annotation from H37Rv (no MTBC0 1:1 anchor; H37Rv protein used): dihydropteroate synthase
  • Pfam (hmmscan --cut_ga): Pterin_bind PF00809.29 (E=8e-87)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq YP_177997.1)
  • Domains: Pfam-A via hmmscan --cut_ga — Pterin_bind (PF00809.29)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0294
  • Curated reference: UniProt P9WND1 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 90.8)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 58 functional partner(s); context anchor folB
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>H37Rv|Rv3608c|folP1
MSPAPVQVMGVLNVTDDSFSDGGCYLDLDDAVKHGLAMAAAGAGIVDVGGESSRPGATRVDPAVETSRVIPVVKELAAQGITVSIDTMRADVARAALQNGAQMVNDVSGGRADPAMGPLLAEADVPWVLMHWRAVSADTPHVPVRYGNVVAEVRADLLASVADAVAAGVDPARLVLDPGLGFAKTAQHNWAILHALPELVATGIPVLVGASRKRFLGALLAGPDGVMRPTDGRDTATAVISALAALHGAWGVRVHDVRASVDAIKVVEAWMGAERIERDG